This compound is a pharmaceutical intermediate featuring a pyrazine ring and a sulfonamide group. It is primarily used in the manufacturing of active pharmaceutical ingredients.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 33288-71-0
1-(diphenylmethyl)azetidin-3-yl methanesulfonate
pharmaceutical intermediate
N-(2-Benzoyl-4-nitrophenyl)-1,3-dihydro-1,3-dioxo-2H-isoindole-2-acetamide
Pharmaceutical intermediate for nitrazepam impurities
Methyl 5-chloropyrazine-2-carboxylate
Pharmaceutical intermediate for rosuvastatin
Adenosine, N-benzoyl-2'-O-(2-methoxyethyl)-
Pharmaceutical intermediate for nucleoside analogs
Ethyl 4-[b-(5-Methylpyrazine-2-carboxamido)ethyl]benzene Sulfonamide Carbamate
Pharmaceutical intermediate
N-(pyrazine-2-yl-carbonyl)-L-phenylalanine
pharmaceutical impurity reference standard
B-[(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid
active pharmaceutical ingredient
N-(Pyrazinylcarbonyl)-L-phenylalanine
Pharmaceutical intermediate
5-methyl-N-[2-(4-sulfamoylphenyl)ethyl]pyrazine-2-carboxamide
IMEZLHZLIANIAS-UHFFFAOYSA-N
CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)N